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Children (≤18 years of age) make up about 25% of the population in the United States1 and, 
therefore, represent a large demographic population who require more planning for different 
medical needs during public health emergencies than adult populations. Within the pediatric 
population, approximately 14% has special health care needs,2 and one in six children has a 
developmental disability.3 The Maternal Child Health Bureau describes children and youth 
with special health care needs (CYSHCN) “as those who have or are at risk for chronic 
physical, developmental, behavioral, or emotional conditions who require health and related 
services of a type or amount beyond that required by children and youth generally.”4 As 
defined, such CYSHCN might need particular attention during some public health 
emergencies. A child’s developmental level, underlying medical condition(s), and mobility 
status may affect his or her need for support, as well as the effectiveness of any medical 
countermeasures such as vaccines or other medications (eg, antimicrobials). Planning and 
targeting of interventions including countermeasures, and nonpharmaceutical interventions 
during an emergency might be necessary to address the increased needs of these specific 
groups of children.
The experience with the 2009 H1N1 pandemic can help plan for the needs of CYSHCN 
during future public health emergencies. Before the pandemic, children with neurologic and 
neurodevelopmental conditions, including those with cerebral palsy, intellectual disability, 
and certain genetic conditions, were found to be at higher risk for severe complications 
associated with seasonal influenza, including complications that resulted in intensive care 
unit admission and death.5–8 Similarly, CYSHCN with influenza A (H1N1) pandemic 2009 
(H1N1) virus infection were at increased risk for hospitalization, intensive care unit 
admission, and death.9–12 In a case series of the first 36 pediatric deaths associated with 
2009 H1N1 reported to the Centers for Disease Control and Prevention (CDC), the majority 
(61%) had an underlying neurologic condition and, of those, 41% had a chronic pulmonary 
condition.13 Experiences with seasonal influenza and the 2009 H1N1 pandemic highlight the 
importance of using standard measures such as vaccination and, when appropriate, antiviral 
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treatment for CYSHCN; for considering additional measures such as school and child care 
center closure; and for planning a future influenza pandemic and other public health 
emergencies and disasters.
ISSUES FOR PREVENTION
2009 H1N1 Vaccination
Because the monovalent 2009 H1N1 vaccine was not going to be available in the United 
States until the fall of 2009, in July 2009 the Advisory Committee on Immunization 
Practices issued a priority list of high-risk populations to be targeted once the 2009 H1N1 
vaccine became available. This list included all children aged six months or older and those 
recognized to be at higher risk for severe complications, such as CYSHCN.14 To ensure that 
these recommendations could be implemented, CDC and the American Academy of 
Pediatrics (AAP) jointly sent letters to immunization coordinators at state health 
departments to highlight these populations with increased vulnerability and need for priority 
vaccination. The CDC worked with AAP and other partners to disseminate information, 
focusing on the special needs of CYSHCN through COCA (Clinician Outreach and 
Communication Activity) calls and webinars for parents and child care providers who care 
for CYSHCN.
Public acceptance of vaccines in general has diminished in the past few years.15 In the 
United States, annual influenza vaccination of all children six months of age or older is 
recommended.16 Many parents are concerned about influenza vaccination and associations 
with adverse outcomes.17–19 Parents of children with neurologic conditions in particular 
may be ambivalent about influenza vaccination of their children, relying instead on good 
hand-washing practices, avoidance of places where a child might be exposed to influenza, 
and optimal nutrition to prevent influenza. Targeting messages to parents of children with 
these conditions is essential in addressing barriers to influenza vaccination. This approach is 
particularly important with vaccines that are new or, as was the case with the 2009 H1N1 
vaccine, are perceived as new. In addition, vaccinating other household members and 
caregivers can help reduce transmission of influenza viruses to CYSHCN.
The AAP recommends that all children with chronic medical conditions have a medical 
home, which means that they receive “accessible, continuous, comprehensive, family 
centered, coordinated, compassionate, and culturally effective care from a team including a 
primary care physician.”20 Primary care providers are strong allies of public health, as they 
work on the front lines to increase influenza vaccine coverage. While they must underscore 
the importance of vaccination for all children, they also should understand and address 
concerns of parents of children at higher risk for serious complications from influenza, such 
as those with neurologic conditions and other CYSHCN. Many of these children are cared 
for by a variety of subspecialty providers in addition to their primary care providers. 
Typically, subspecialists do not administer vaccinations; however, they are in an ideal 
position to emphasize the importance of vaccination by primary care providers and 
encourage influenza vaccination so that opportunities for vaccination are not missed.21 In a 
public health emergency situation, pediatric health care providers must be made aware of the 
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needs of vulnerable children and work with their families to ensure the success of any public 
health response that involves mass vaccination.
Influenza vaccine effectiveness varies from year to year, depending in part on the match 
between circulating influenza viruses and vaccine strains22; effectiveness also can vary 
among specific populations. Hara and colleagues found decreased immunogenicity to the 
2009 H1N1 vaccine among individuals with severe motor and intellectual disability.23 
Consecutive doses in the same season did not improve immunogenicity among these 
individuals. While vaccination is still strongly recommended, providers and parents of such 
children needed to be informed about these findings and the need for additional strategies to 
prevent influenza among these vulnerable children.
Antiviral Treatment
Antiviral treatment of influenza is most effective when started early (within two days of 
illness onset), and has continued clinical benefit when antiviral agents are initiated through 
four days after illness onset.23,24 Because CYSHCN are at high risk for severe 
complications from seasonal influenza and pandemic influenza, and influenza vaccination is 
not 100% effective, providers must educate parents about the importance of bringing ill 
children with possible influenza for medical evaluation as soon as possible so that antiviral 
treatment can be initiated promptly if influenza is suspected or proven.25 For CYSHCN who 
live in long-term care facilities, prompt recognition of an influenza outbreak, even among 
vaccinated children, and prompt implementation of control measures, including antiviral 
treatment of ill children and antiviral chemoprophylaxis when appropriate, is critical.26 
During the pandemic, CDC worked with other federal partners and national professional 
groups to host COCA calls presenting cases of children who were critically ill to assist in 
sharing information about treatment of influenza.
ISSUES FOR NONPHARMACEUTICAL INTERVENTIONS
Young children with complex medical conditions may be cared for during the day, either in 
specialized (“medical”) or traditional child care settings. Children in medical child care 
settings receive skilled nursing services and other therapies that are not offered in traditional 
child care settings. Both settings require consideration of the child’s special needs to protect 
him or her from influenza. In addition, the possible effects on the child and family when 
these services are not available must be considered.27 During the 2009 H1N1 pandemic, 
CDC held webinars for child care providers working at Easter Seals facilities, child care 
centers at Young Men’s Christian Associations (YMCAs), and other child care 
organizations, as well as coordinated weekly telephone calls with leaders in child care 
including those in leadership roles in national child care associations and directors of large 
child care organizations, to discuss potential problems and solutions to issues they were 
dealing with during the pandemic. Planning to minimize transmission of influenza through 
nonpharmaceutical interventions, such as social distancing and encouraging good hand 
washing, as well as through vaccination of staff and children who are in these settings, can 
decrease the number of children who become ill. Similarly, in school settings, whether the 
CYSHCN are in a classroom with typical peers or in specialized classrooms or schools, 
planning for influenza outbreaks or other emergencies should occur.
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In addition to influenza vaccination of all child care staff, practicing good hand and 
respiratory hygiene and cough etiquette can help prevent influenza virus transmission to or 
from CYSHCN. Caregivers need to be educated that such children are at high risk for severe 
influenza complications and to notify parents about possible exposures to other children or 
staff with acute respiratory illness. In specialized child care settings that include children 
with neurologic or medically complex conditions with healthy peers or for child care centers 
that provide care only to CYSHCN, discussion of planning for proactive closure to prevent 
the spread of illness should be considered. School nurses or child care health consultants can 
assist child care facilities, schools, and parents in planning what to do during an outbreak or 
emergency event. During the 2009 H1N1 pandemic, some camps serving children with 
special medical conditions such as muscular dystrophy were closed proactively to prevent 
transmission of pandemic influenza. Planning for influenza outbreaks among CYSHCN at 
child care centers and special camps also can be informative for preparing for other types of 
emergencies and disasters.
CONCLUSIONS
CYSHCN potentially have greater needs during public health emergencies, and many of 
these can be anticipated ahead of time. Different public health emergency situations might 
confer higher risk for poor outcomes among different subsets of CYSHCN, depending on 
their particular areas of vulnerability. The 2009 H1N1 pandemic had a major effect on 
CYSHCN and, together with data from seasonal influenza, has highlighted the increased 
vulnerability of children with chronic neurologic, developmental, and pulmonary conditions 
for severe and fatal influenza outcomes. Parents and providers of CYSHCN should be 
educated about prevention and control of seasonal and pandemic influenza, including the 
need for influenza vaccination, early antiviral treatment, nonpharmaceutical interventions, 
and advance planning.
A better, more complete understanding by providers of the needs of families and CYSHCN, 
as well as awareness by those families about the needs of their children, during a public 
health emergency is needed. To formulate targeted interventions, research is needed to 
identify which children with specific conditions are at heightened risk during different 
emergency situations. Specific guidelines and health education messages targeting these 
special populations should be developed for families of CYSHCN and health care providers 
to optimize care during future public health emergencies.
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